SEC Form 4 · accession 0001214659-16-010590
NEULION, INC. · NLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Christopher Wagner
Officer — EVP, Marketplace Strategy
Period of report
Mar 29, 2016
Accepted (ET)
Mar 31, 2016 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001387713
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 29, 2016 | S | 63,930 | $0.7821 | D | 1,215,323 | D | |
| Restricted Common StockF3 | holding | — | — | — | 200,000 | D | ||
| Restricted Common StockF4 | holding | — | — | — | 600,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Wagner sold these shares to Charles B. Wang, the Chairman of the Board of Directors of NeuLion.
- F2The purchase price of each share was $0.7821, which was the 5 day volume weighted average price of NeuLion's common stock on the Toronto Stock Exchange ending March 28, 2016.
- F3The reporting person was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on May 18, 2015.
- F4The reporting person was granted these restricted shares subject to the terms of the Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan. The restricted shares vest at a rate of one-quarter of their allotted amount per year over four years. Vesting began on March 7, 2016.